Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

The topic and treatment of contagious disease has become controversial since COVID-19 came along, but what is not ...

William Schaffner: The most important thing is good hand hygiene. Washing with soap and water works the best. Those hand ...

Ohio Department of Health director Dr. Bruce Vanderhoff cautioned Ohioans to continue to take these illnesses seriously.

The virus, which is more prevalent during winter and spring, can cause flu-like symptoms and affect the upper respiratory system. In some cases, it can lead to lower respiratory infections.

Winter also marks the height of the respiratory virus season, a period of sniffles, sneezes, congestion, fever and other maladies brought about primarily by four pathogens: the respiratory syncytial ...

Respiratory syncytial virus (RSV) causes cold-like symptoms in most people but can cause more serious problems in some, especially babies and older adults. Almost all children get RSV at least once by ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

including the seasonal flu and respiratory syncytial virus (RSV). HMPV is not like Covid-19 and experts say fears of a pandemic are overblown. Pandemics are typically caused by novel pathogens ...

Though HMPV shares similarities with other respiratory viruses like RSV (Respiratory Syncytial Virus), measles, and mumps, it does not have a vaccine, and no antiviral treatments are available.